ISAB — Inhalation Sciences Sweden AB Share News
0.000.00%
Last trade - 00:00- SEK10.28m
- SEK6.89m
- SEK3.04m
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna
Brief: Inhalation Sciences Gets Order Worth SEK 1.4 Mln
Brief: Inhalation Sciences Secures Important IP Rights
Brief: Inhalation Sciences Signs Joint Development Project Worth EUR 25,000
Brief: Inhalation Sciences Sweden Q2 Operating Loss Widens To SEK 3.8 Million
Brief: Inhalation Sciences Signs Contract Worth EUR 75,000
Brief: Inhalation Sciences Sweden Signs Contract With Teva Pharmaceuticals
Brief: Inhalation Sciences Signs Global Distribution Agreement With TSE Systems
Brief: Inhalation Sciences Sweden Divests Holding In Ziccum Securing Long-Term Financing
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 2.0 Mln
Brief: Inhalation Sciences Signs CRO Contract Worth SEK 750,000
Brief: Inhalation Sciences Preliminary 2019 Revenue Rises To SEK 8.8 Mln
Brief: Inhalation Sciences Receives Order Worth About 3 MSEK From Leading Big Pharma Company
Brief: Inhalation Sciences Changes CEO
Brief: Inhalation Sciences Gets Order Worth SEK 1.8 Million
Brief: Inhalation Sciences To Conduct SEK 1 Mln Cro Study For Major European Pharma Company